Plus   Neg

Exact Sciences Corp. (EXAS) Is Up Sharply On Pfizer Deal

Exact Sciences Corp. (EXAS) and Pfizer Inc. (PFE) announced an agreement Wednesday morning to co-promote Cologuard through 2021.

Exact Sciences gapped open sharply higher this morning and is now up 10.92 at $60.97. The stock has climbed to a 3-week high.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT